New technique creates stem cells that grow faster

Stem cell therapy is often hailed as the treatment of the future for several diseases. And mesenchymal stem cells (MSCs)—which can be derived from both embryonic cells and adult cell sources, such as bone marrow, blood, and adipose tissue—have shown particular promise. MSCs are now being tested in more than 350 clinical trials.

What makes MSCs special is that they do not express certain cellular markers and thereby manage to evade the immune system. This means they can be administered therapeutically without suppressing the patient’s immune system—a necessity with most grafts and organ transplants. Further, MSCs seem to move toward damaged tissue and assist in repair by both differentiating into key cells themselves, and by recruiting other repair factors to the site. But making MSCs of consistent quality and sufficient quantity to treat patients has been tricky.

Read the full, original story: Making Better Mesenchymal Stem Cells

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend